Skip to Content

Notice

Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS).

ACTION:

Notice.

SUMMARY:

HHS gives notice concerning the final effect of the HHS decision to designate a class of employees from Vitro Manufacturing, Canonsburg, Pennsylvania, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On April 29, 2011, as provided for under 42 U.S.C. 7384q(b), the Secretary of HHS designated the following class of employees as an addition to the SEC:

All Atomic Weapons Employer employees who worked at Vitro Manufacturing in Canonsburg, Pennsylvania, from January 1, 1958 through December 31, 1959, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.

This designation became effective on May 29, 2011, as provided for under 42 U.S.C. 7384 l (14)(C). Hence, beginning on May 29, 2011, members of this class of employees, defined as reported in this notice, became members of the Special Exposure Cohort.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, OH 45226, Telephone 877-222-7570. Information requests can also be submitted by e-mail to dcas@cdc.gov.

Start Signature

John Howard,

Director, National Institute for Occupational Safety and Health.

End Signature End Further Info End Preamble

[FR Doc. 2011-14354 Filed 6-8-11; 8:45 am]

BILLING CODE 4163-19-P